The United States Government—through the United States Agency for International Development (USAID) —announces an additional $4 million in urgent COVID-19 assistance funding for Botswana. This additional assistance from the historic American Rescue Plan Act builds on more than $8.4 million in COVID-19 assistance to Botswana since the pandemic first emerged. This assistance supports the Government of Botswana to strengthen infection prevention and control in communities and at health facilities, establish vaccination sites, strengthen surveillance at border crossings, provide support for isolation facilities for COVID-19 patients, and support the Government of Botswana’s planning efforts.
“We will continue to do all we can – whether it be through our vaccine donations or through U.S. global health funding – to build a world that is safer and more secure against the threat of infectious disease,” said U.S. Ambassador Cloud.
This additional four million dollars will continue to support the Government of Botswana’s vaccination efforts through strengthening supply chains, vaccination sites, community promotion and education, and infection prevention and control. It will also support the Ministry of Health and Wellness’s home isolation strategy.
These efforts build on decades of U.S. leadership in tackling global health crises. Over the past 60 years, the U.S. government has saved millions of lives globally from diseases such as Ebola, HIV/AIDS, tuberculosis, malaria, and now COVID-19.
Diseases know no borders. The U.S. is committed to partnering with Botswana to end the COVID-19 pandemic, mitigate its devastating social and economic impacts, and build back a world that is better prepared for future outbreaks.
For additional information on U.S. COVID-19 assistance refer to our COVID-19 Assistance Fact Sheet.
Distributed by APO Group on behalf of U.S. Embassy in Botswana.
© Press Release 2021
Disclaimer: The contents of this press release was provided from an external third party provider. This website is not responsible for, and does not control, such external content. This content is provided on an “as is” and “as available” basis and has not been edited in any way. Neither this website nor our affiliates guarantee the accuracy of or endorse the views or opinions expressed in this press release.
The press release is provided for informational purposes only. The content does not provide tax, legal or investment advice or opinion regarding the suitability, value or profitability of any particular security, portfolio or investment strategy. Neither this website nor our affiliates shall be liable for any errors or inaccuracies in the content, or for any actions taken by you in reliance thereon. You expressly agree that your use of the information within this article is at your sole risk.
To the fullest extent permitted by applicable law, this website, its parent company, its subsidiaries, its affiliates and the respective shareholders, directors, officers, employees, agents, advertisers, content providers and licensors will not be liable (jointly or severally) to you for any direct, indirect, consequential, special, incidental, punitive or exemplary damages, including without limitation, lost profits, lost savings and lost revenues, whether in negligence, tort, contract or any other theory of liability, even if the parties have been advised of the possibility or could have foreseen any such damages.
